Trial · NCT00535938
Adverse events106
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 106
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| serious | Foot Deformity | Musculoskeletal and connective tissue disorders | Naïve to Botox® Treatment | 1 | 506 | |
| serious | Foot Deformity | Musculoskeletal and connective tissue disorders | Non-naïve to Botox® Treatment | 0 | 866 | |
| serious | Dysphagia | Gastrointestinal disorders | Naïve to Botox® Treatment | 1 | 506 | |
| serious | Dysphagia | Gastrointestinal disorders | Non-naïve to Botox® Treatment | 4 | 866 | |
| serious | Multiple Sclerosis | Nervous system disorders | Naïve to Botox® Treatment | 1 | 506 | |
| serious | Multiple Sclerosis | Nervous system disorders | Non-naïve to Botox® Treatment | 0 | 866 | |
| serious | Neoplasm Malignant | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Naïve to Botox® Treatment | 1 | 506 | |
| serious | Neoplasm Malignant | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Non-naïve to Botox® Treatment | 0 | 866 | |
| serious | Death | General disorders | Naïve to Botox® Treatment | 1 | 506 | |
| serious | Death | General disorders | Non-naïve to Botox® Treatment | 6 | 866 | |
| serious | Intervertebral Disc Protrusion | Musculoskeletal and connective tissue disorders | Naïve to Botox® Treatment | 0 | 506 | |
| serious | Intervertebral Disc Protrusion | Musculoskeletal and connective tissue disorders | Non-naïve to Botox® Treatment | 1 | 866 | |
| serious | Lumbar Radiculopathy | Nervous system disorders | Naïve to Botox® Treatment | 0 | 506 | |
| serious | Lumbar Radiculopathy | Nervous system disorders | Non-naïve to Botox® Treatment | 1 | 866 | |
| serious | Urosepsis | Infections and infestations | Naïve to Botox® Treatment | 0 | 506 | |
| serious | Urosepsis | Infections and infestations | Non-naïve to Botox® Treatment | 1 | 866 | |
| serious | Pyrexia | General disorders | Naïve to Botox® Treatment | 0 | 506 | |
| serious | Pyrexia | General disorders | Non-naïve to Botox® Treatment | 1 | 866 | |
| serious | Haematuria | Renal and urinary disorders | Naïve to Botox® Treatment | 0 | 506 | |
| serious | Haematuria | Renal and urinary disorders | Non-naïve to Botox® Treatment | 1 | 866 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00535938/events